# Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice

> **NCT01083849** · — · COMPLETED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 761 (actual)

## Conditions studied

- Kidney Insufficiency
- Secondary Hyperparathyroidism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01083849
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 761 (ACTUAL)
- **Last updated:** 2014-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01083849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01083849, "Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01083849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*